Chrome Extension
WeChat Mini Program
Use on ChatGLM

Afatinib (Afa) plus bevacizumab (Bev) versus afatinib alone as first-line treatment of patients with EGFR-mutated advanced non-squamous NSCLC: Primary analysis of the multicenter, randomized, phase II study-AfaBev-CS study.

JOURNAL OF CLINICAL ONCOLOGY(2022)

Cited 0|Views13
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined